Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
23.51
+0.24 (1.03%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Apollomics Employees
Apollomics had 14 employees as of December 31, 2025. The number of employees increased by 1 or 7.69% compared to the previous year.
Employees
14
Change (1Y)
1
Growth (1Y)
7.69%
Revenue / Employee
$631,571
Profits / Employee
-$781,357
Market Cap
51.63M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14 | 1 | 7.69% |
| Dec 31, 2024 | 13 | -32 | -71.11% |
| Dec 31, 2023 | 45 | 2 | 4.65% |
| Dec 31, 2022 | 43 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Elicio Therapeutics | 33 |
| eXoZymes | 32 |
| INmune Bio | 21 |
| ImageneBio | 18 |
| Edesa Biotech | 17 |
| Instil Bio | 17 |
| Serina Therapeutics | 16 |
APLM News
- 6 weeks ago - Apollomics announces $10M private placement transaction - TheFly
- 7 weeks ago - Apollomics Announces $10 Million Private Placement Transaction - GlobeNewsWire
- 2 months ago - Apollomics Inc trading resumes - TheFly
- 2 months ago - Apollomics Inc trading halted, volatility trading pause - TheFly
- 2 months ago - Apollomics regains compliance with Nasdaq listing requirements - TheFly
- 2 months ago - Apollomics Regains Full Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 3 months ago - Apollomics Inc trading resumes - TheFly
- 3 months ago - Apollomics Inc trading halted, volatility trading pause - TheFly